Powerful, array-based technology can differentiate subclass of cancer by determining deletion or amplification of certain characteristic genes. This method has been applied in renal cancer model to evaluate its potential application in differential diagnosis. The study demonstrated that automated high throughput techniques to screen the entire genome for abnormality could become a feasible approach in cancer management.
Go to Previous Page
Go to Next Page